Stockreport

Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com
PDF This article first appeared on GuruFocus Total Revenue: $172.4 million for 2025. Revuforj Net Revenue: $124.8 million in 2025, with a 38% increase in Q4 compared to [Read more]